LETROZOLE Side Effects

6945000-2 | Hyperbilirubinaemia, Polycythaemia
on Aug 13, 2010 Male patient from UNITED STATES , 13 years of age, was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia, polycythaemia. Letrozole dosage: 2.5 Mg Per Day.

6942405-0 | Haematocrit Increased, Haemoglobin Increased, Hyperbilirubinaemia, Polycythaemia
Patient was taking Letrozole (View Usage). Patient had the following side effects: haematocrit increased, haemoglobin increased, hyperbilirubinaemia, polycythaemia on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, . Letrozole dosage: 2.5 Mg Per Day.

6909285-0 | Arthralgia, Arthropathy, Breast Cancer Recurrent, Hypergammaglobulinaemia, Joint Stiffness, Metastases To Bone, Metastases To Liver, Metastases To Lung, Rheumatoid Arthritis
Adverse event was reported on Jul 23, 2010 by a Female patient taking Letrozole (View Usage) (Dosage: Unk) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , 66 years of age, After Letrozole was administered, patient had the following side effects: arthralgia, arthropathy, breast cancer recurrent, hypergammaglobulinaemia, joint stiffness, metastases to bone, metastases to liver, metastases to lung, rheumatoid arthritis (What is rheumatoid arthritis?).

6907906-X | Arthralgia, Joint Swelling, Rheumatoid Arthritis, Sicca Syndrome
on Jul 23, 2010 Female patient from FRANCE , 61 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, joint swelling, rheumatoid arthritis (What is rheumatoid arthritis?), sicca syndrome. Letrozole dosage: Unk. During the same period patient was treated with EXEMESTANE (Unk) (View Exemestane Review and Exemestane Label ).


6836934-8 | Multiple Pregnancy, Selective Abortion
on Jun 16, 2010 Female patient from UNITED STATES , 32 years of age, was diagnosed with ovulation induction and was treated with Letrozole (View Usage). Patient had the following side effects: multiple pregnancy, selective abortion. Letrozole dosage: 5 Mg/day On Cyle Days 2 To 6. During the same period patient was treated with METFORMIN (750 Mg, Bid) (View Metformin Review and Metformin Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), LUTEINISING HORMONE (HUMAN) (View Luteinising Hormone (human) Review and Luteinising Hormone (human) Label ).

6756314-3 | Blood Testosterone Increased
Patient was taking Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: blood testosterone increased on May 13, 2010 from CHILE Additional patient health information: Male patient , 19 years of age, . Letrozole dosage: 1.5 Mg/day.

6756311-8 | Colectomy, Colon Cancer, Large Intestinal Ulcer, Resection Of Rectum
Adverse event was reported on May 19, 2010 by a Female patient taking Letrozole (View Usage) (Dosage: Unk) . Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: colectomy, colon cancer, large intestinal ulcer, resection of rectum.

6403086-8 | Pancreatitis
on Oct 05, 2009 Female patient from UNITED KINGDOM , 66 years of age, was diagnosed with breast cancer (What is breast cancer?), hypertension, depression (What is depression?) and was treated with Letrozole (View Usage). Patient had the following side effects: pancreatitis. Letrozole dosage: 2.5 Mg, Unk. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Mg, Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), FLUOXETINE (20 Mg, Unk) (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6337329-6 | Pregnancy
on Aug 28, 2009 Female patient from UNITED STATES , 47 years of age, weighting 146.0 lb, was diagnosed with infertility (What is infertility?), off label use and was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: pregnancy (What is pregnancy?). Letrozole dosage: 2.5 Mg 5 Days Of Cycle Po.

6269880-1 | Anaemia Haemolytic Autoimmune, Asthenia, Blood Bilirubin Increased, Coombs Direct Test Positive, Coombs Indirect Test Positive, Fatigue, Haptoglobin Decreased, Reticulocyte Count Increased
Patient was taking Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune, asthenia, blood bilirubin increased, coombs direct test positive, coombs indirect test positive, fatigue, haptoglobin decreased, reticulocyte count increased on Jul 01, 2009 from LEBANON Additional patient health information: Female patient , weighting 169.8 lb, was diagnosed with breast cancer (What is breast cancer?) and. Letrozole dosage: 2.5 Mg Daily. During the same period patient was treated with CIPROFLOXACIN (250 Mg, Bid) (View Ciprofloxacin Review and Ciprofloxacin Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6046600-7 | Blood Creatinine Increased, Tubulointerstitial Nephritis
Adverse event was reported on Jan 13, 2009 by a Female patient taking Letrozole (View Usage) (Dosage: 2.5 Mg, Unk) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , 62 years of age, Patient had the following side effects: blood creatinine increased, tubulointerstitial nephritis. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (75 Mg) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

6045138-0 | Blood Pressure Systolic Increased, Cerebrovascular Accident, Impaired Work Ability, Myodesopsia, Transient Ischaemic Attack, Vision Blurred
on Jan 16, 2009 Female patient from UNITED STATES , 39 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: blood pressure systolic increased, cerebrovascular accident, impaired work ability, myodesopsia, transient ischaemic attack, vision blurred. Letrozole dosage: 2.5 Mg Everyday Po. Patient was hospitalized.

5987472-6 | Coma, Progressive Multifocal Leukoencephalopathy
on Dec 01, 2008 Female patient from UNITED KINGDOM , 61 years of age, was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: coma, progressive multifocal leukoencephalopathy. Letrozole dosage: . During the same period patient was treated with DOCETAXEL (100 Mg/m2) (View Docetaxel Review and Docetaxel Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), NEULASTA (View Neulasta Review and Neulasta Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5984366-7 | Coma, Progressive Multifocal Leukoencephalopathy
Patient was taking Letrozole (View Usage). Patient had the following side effects: coma, progressive multifocal leukoencephalopathy on Dec 01, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, . Letrozole dosage: . During the same period patient was treated with DOCETAXEL (100 Mg/m2) (View Docetaxel Review and Docetaxel Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), NEULASTA (View Neulasta Review and Neulasta Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5984333-3 | Affect Lability, Coma, Nuclear Magnetic Resonance Imaging Brain Abnormal, Progressive Multifocal Leukoencephalopathy
Adverse event was reported on Dec 01, 2008 by a Female patient taking Letrozole (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , 61 years of age, After Letrozole was administered, patient had the following side effects: affect lability, coma, nuclear magnetic resonance imaging brain abnormal, progressive multifocal leukoencephalopathy. During the same period patient was treated with NEULASTA (View Neulasta Review and Neulasta Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOCETAXEL (100 Mg/ M^2) (View Docetaxel Review and Docetaxel Label ), EPIRUBICIN (Unk) (View Epirubicin Review and Epirubicin Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ).

5953286-6 | Blood Albumin Decreased, Blood Potassium Increased, Blood Urea Increased, C-reactive Protein Increased, Haematocrit Decreased, Haemoglobin Decreased, Mean Cell Haemoglobin Decreased, Mean Cell Volume Abnormal
on Nov 10, 2008 Female patient from UNITED KINGDOM , 80 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood potassium increased, blood urea increased, c-reactive protein increased, haematocrit decreased, haemoglobin decreased, mean cell haemoglobin decreased, mean cell volume abnormal. Letrozole dosage: Unk.

5953255-6 | Biopsy Skin, Cutaneous Vasculitis, Parakeratosis, Skin Lesion
on Nov 06, 2008 Female patient from UNITED STATES , 62 years of age, was diagnosed with breast cancer stage iv and was treated with Letrozole (View Usage). Patient had the following side effects: biopsy skin, cutaneous vasculitis, parakeratosis, skin lesion. Letrozole dosage: . During the same period patient was treated with ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), FULVESTRANT (View Fulvestrant Review and Fulvestrant Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ).

5937135-8 | Coma, Progressive Multifocal Leukoencephalopathy
Patient was taking Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: coma, progressive multifocal leukoencephalopathy on Oct 23, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, . Letrozole dosage: . During the same period patient was treated with DOCETAXEL (100 Mg/m2) (View Docetaxel Review and Docetaxel Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), NEULASTA (View Neulasta Review and Neulasta Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5916254-6 | Multiple Pregnancy, Selective Abortion
Adverse event was reported on Oct 03, 2008 by a Female patient taking Letrozole (View Usage) (Dosage: 5 Mg/day On Cyle Days 2 To 6) was diagnosed with ovulation induction and. Location: UNITED STATES , 32 years of age, Patient experienced the following unwanted or unexpected effects: multiple pregnancy, selective abortion. During the same period patient was treated with METFORMIN HCL (750 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), LUTEINISING HORMONE (HUMAN) (View Luteinising Hormone (human) Review and Luteinising Hormone (human) Label ).

5909901-6 | Coma, Nuclear Magnetic Resonance Imaging Brain Abnormal, Progressive Multifocal Leukoencephalopathy
on Oct 02, 2008 Female patient from UNITED KINGDOM , 61 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). Patient had the following side effects: coma, nuclear magnetic resonance imaging brain abnormal, progressive multifocal leukoencephalopathy. Letrozole dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOCETAXEL (100 Mg/ M^2) (View Docetaxel Review and Docetaxel Label ), EPIRUBICIN (Unk) (View Epirubicin Review and Epirubicin Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ).

5888848-8 | Actinomycosis, Bone Disorder, Bone Trimming, Chest Wall Operation, Inflammation, Jaw Disorder, Neoplasm Recurrence, Osteonecrosis
on Sep 09, 2008 Female patient from UNITED STATES , 51 years of age, was diagnosed with breast cancer (What is breast cancer?), neoplasm recurrence and was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: actinomycosis, bone disorder, bone trimming, chest wall operation, inflammation, jaw disorder, neoplasm recurrence, osteonecrosis (What is osteonecrosis?). Letrozole dosage: Unk. During the same period patient was treated with BEVACIZUMAB (15 Mg/kg, Unk) (View Bevacizumab Review and Bevacizumab Label ), HORMONES NOS (View Hormones Nos Review and Hormones Nos Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), CAPECITABINE (1000 Mg, Bid) (View Capecitabine Review and Capecitabine Label ).

5880274-0 | Abdominal Pain Lower, Acute Hepatic Failure, Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased
Patient was taking Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, acute hepatic failure, alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased on Sep 05, 2008 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with breast cancer (What is breast cancer?), disease recurrence, renal cancer and. Letrozole dosage: . During the same period patient was treated with SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

5853700-0 | Biopsy Skin, Cutaneous Vasculitis, Parakeratosis, Skin Lesion
Adverse event was reported on Aug 15, 2008 by a Female patient taking Letrozole (View Usage) (Dosage: ) was diagnosed with breast cancer stage iv and. Location: UNITED STATES , 62 years of age, Patient had the following side effects: biopsy skin, cutaneous vasculitis, parakeratosis, skin lesion. During the same period patient was treated with ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), FULVESTRANT (View Fulvestrant Review and Fulvestrant Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ).

5782957-X | Neutropenia
on Jun 10, 2008 Female patient from UNITED KINGDOM , 85 years of age, was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: neutropenia. Letrozole dosage: . During the same period patient was treated with ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), ZOPLICONE (View Zoplicone Review and Zoplicone Label ).

5767837-8 | Anaphylactic Reaction
on Jun 10, 2008 Female patient from UNITED KINGDOM , 57 years of age, was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Letrozole dosage: Unk. Patient was hospitalized.

5710687-9 | Concomitant Disease Progression, Eye Oedema, Visual Acuity Reduced
Patient was taking Letrozole (View Usage). Patient had the following side effects: concomitant disease progression, eye oedema, visual acuity reduced on Apr 08, 2008 from ITALY Additional patient health information: Female patient , 77 years of age, weighting 187.4 lb, was diagnosed with breast cancer (What is breast cancer?) and. Letrozole dosage: 2.5 Mg, Qd.

5710685-5 | Concomitant Disease Progression, Eye Oedema, Visual Acuity Reduced
Adverse event was reported on Apr 08, 2008 by a Female patient taking Letrozole (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with breast cancer (What is breast cancer?) and. Location: ITALY , 77 years of age, weighting 187.4 lb, After Letrozole was administered, patient had the following side effects: concomitant disease progression, eye oedema, visual acuity reduced.

5702686-8 | Fatigue, Hydropneumothorax, Metastases To Spine, Pericardial Effusion, Pleural Effusion, Refusal Of Treatment By Patient
on Apr 10, 2008 Female patient from UNITED STATES , 62 years of age, weighting 186.5 lb, was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, hydropneumothorax, metastases to spine, pericardial effusion, pleural effusion, refusal of treatment by patient. Letrozole dosage: 2.5mg Daily Po. Patient was hospitalized.

5699451-7 | Arthralgia, Myalgia
on Apr 07, 2008 Female patient from UNITED STATES , 78 years of age, weighting 201.0 lb, was diagnosed with breast cancer stage i, oestrogen receptor assay positive and was treated with Letrozole (View Usage). Patient had the following side effects: arthralgia, myalgia. Letrozole dosage: 2.5 Mg Daily Oral.

5697839-1 | Abasia, Activities Of Daily Living Impaired, Arthralgia, Depression, Disturbance In Attention, Fatigue, Impaired Work Ability, Insomnia, Muscular Weakness
Patient was taking Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: abasia, activities of daily living impaired, arthralgia, depression (What is depression?), disturbance in attention, fatigue, impaired work ability, insomnia, muscular weakness on Apr 04, 2008 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 158.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Letrozole dosage: 2.5 1x Po.

5693254-5 | Myositis, Pain In Extremity, Swelling, Vein Disorder
Adverse event was reported on Mar 27, 2008 by a Female patient taking Letrozole (View Usage) (Dosage: 2.5mg) was diagnosed with breast cancer (What is breast cancer?), osteopenia and. Location: BELGIUM , 53 years of age, weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: myositis (What is myositis?), pain in extremity, swelling, vein disorder. During the same period patient was treated with ZOLEDRONIC ACID (4mg) (View Zoledronic Acid Review and Zoledronic Acid Label ).

5693251-X | Myositis, Pain In Extremity, Swelling, Vein Disorder
on Mar 27, 2008 Female patient from BELGIUM , 53 years of age, weighting 127.9 lb, was diagnosed with breast cancer (What is breast cancer?), osteopenia and was treated with Letrozole (View Usage). Patient had the following side effects: myositis (What is myositis?), pain in extremity, swelling, vein disorder. Letrozole dosage: 2.5mg. During the same period patient was treated with ZOLEDRONIC ACID (4mg) (View Zoledronic Acid Review and Zoledronic Acid Label ).

5675707-9 | Polyneuropathy
on Mar 14, 2008 Female patient from SPAIN , 70 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: polyneuropathy. Letrozole dosage: .

5675702-X | Carpal Tunnel Decompression, Carpal Tunnel Syndrome
Patient was taking Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: carpal tunnel decompression, carpal tunnel syndrome (What is carpal tunnel syndrome?) on Mar 14, 2008 from BELGIUM Additional patient health information: Female patient , 55 years of age, weighting 112.4 lb, was diagnosed with breast cancer (What is breast cancer?) and. Letrozole dosage: 2.5 Mg, Qd. During the same period patient was treated with ZOLEDRONIC ACID (3.3mg Every 6 Months) (View Zoledronic Acid Review and Zoledronic Acid Label ). Patient was hospitalized.

5672635-X | Premature Baby
Adverse event was reported on Mar 12, 2008 by a Female patient taking Letrozole (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 2.52 lb, Patient had the following side effects: premature baby. During the same period patient was treated with REBIF (Maternal Dosing: 44 Mcg, Three Times Weekly) (View Rebif Review and Rebif Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ). Patient was hospitalized.

5672378-2 | Caesarean Section, Continuous Positive Airway Pressure, Premature Baby
on Mar 12, 2008 Female patient from UNITED STATES , weighting 2.83 lb, was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: caesarean section, continuous positive airway pressure, premature baby. Letrozole dosage: . During the same period patient was treated with REBIF (Maternal Dosing: 44 Mcg, Three Times Weekly) (View Rebif Review and Rebif Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ). Patient was hospitalized.

5669374-8 | Foetal Growth Retardation, Mechanical Ventilation, Premature Baby
on Mar 12, 2008 Male patient from UNITED STATES , weighting 1.70 lb, was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: foetal growth retardation, mechanical ventilation, premature baby. Letrozole dosage: . During the same period patient was treated with REBIF (Maternal Dose: 44 Mcg, Three Times Weekly) (View Rebif Review and Rebif Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ). Patient was hospitalized.

5669300-1 | Myositis, Oedema Peripheral, Pain In Extremity, Vein Disorder
Patient was taking Letrozole (View Usage). Patient had the following side effects: myositis (What is myositis?), oedema peripheral, pain in extremity, vein disorder on Mar 05, 2008 from BELGIUM Additional patient health information: Female patient , 53 years of age, weighting 127.9 lb, was diagnosed with breast cancer (What is breast cancer?), osteopenia and. Letrozole dosage: 2.5mg. During the same period patient was treated with ZOLEDRONIC ACID (4mg) (View Zoledronic Acid Review and Zoledronic Acid Label ).

5657975-2 | Hepatic Function Abnormal, Jaundice
Adverse event was reported on Feb 28, 2008 by a Female patient taking Letrozole (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: NETHERLANDS , 85 years of age, After Letrozole was administered, patient had the following side effects: hepatic function abnormal, jaundice (What is jaundice?). During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZID ^HARRIS^ (1 Df, Qd) (View Triamterene And Hydrochlorothiazid ^harris^ Review and Triamterene And Hydrochlorothiazid ^harris^ Label ), METFORMIN HCL (850 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5657315-9 | Abdominal Pain Upper, Arthralgia, Mucosal Inflammation, Nausea
on Feb 28, 2008 Female patient from BELGIUM , 68 years of age, weighting 158.7 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, arthralgia, mucosal inflammation, nausea (What is nausea?). Letrozole dosage: 2.5 Unk, Qd.

5657313-5 | Bronchopneumonia, Dehydration, Embolism, Lethargy, Nausea, Pulmonary Haemorrhage, Pyrexia, Rash Erythematous, Staphylococcal Infection
on Mar 03, 2008 Female patient from AUSTRALIA , 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Letrozole (View Usage). Patient had the following side effects: bronchopneumonia, dehydration, embolism, lethargy, nausea (What is nausea?), pulmonary haemorrhage, pyrexia, rash erythematous, staphylococcal infection (What is staphylococcal infection?). Letrozole dosage: 2.5 Mg, Qd. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), RAD001 AND LETROZOLE (10mg, Daily) (View Rad001 And Letrozole Review and Rad001 And Letrozole Label ). Patient was hospitalized.

5640559-X | Bronchopneumonia, Dehydration, Lethargy, Nausea, Pyrexia, Rash Erythematous, Staphylococcal Infection, Staphylococcal Sepsis
Patient was taking Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: bronchopneumonia, dehydration, lethargy, nausea (What is nausea?), pyrexia, rash erythematous, staphylococcal infection (What is staphylococcal infection?), staphylococcal sepsis on Feb 19, 2008 from AUSTRALIA Additional patient health information: Female patient , 56 years of age, was diagnosed with non-small cell lung cancer and. Letrozole dosage: 2.5 Mg, Qd. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), RAD001 AND LETROZOLE (10mg, Daily) (View Rad001 And Letrozole Review and Rad001 And Letrozole Label ). Patient was hospitalized.

5632280-9 | Foetal Growth Retardation, Mechanical Ventilation, Premature Baby
Adverse event was reported on Feb 06, 2008 by a Male patient taking Letrozole (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 1.70 lb, Patient experienced the following unwanted or unexpected effects: foetal growth retardation, mechanical ventilation, premature baby. During the same period patient was treated with REBIF (Maternal Dose: 44 Mcg, Three Times Weekly) (View Rebif Review and Rebif Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ). Patient was hospitalized.

5629832-9 | Premature Baby
on Feb 06, 2008 Female patient from UNITED STATES , weighting 2.52 lb, was treated with Letrozole (View Usage). Patient had the following side effects: premature baby. Letrozole dosage: . During the same period patient was treated with REBIF (Maternal Dosing: 44 Mcg, Three Times Weekly) (View Rebif Review and Rebif Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ). Patient was hospitalized.

5629811-1 | Continuous Positive Airway Pressure, Premature Baby
on Feb 06, 2008 Female patient from UNITED STATES , weighting 2.83 lb, was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: continuous positive airway pressure, premature baby. Letrozole dosage: . During the same period patient was treated with REBIF (Maternal Dosing: 44 Mcg, Three Times Weekly) (View Rebif Review and Rebif Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ). Patient was hospitalized.

5625991-2 | Dehydration, Lethargy, Nausea, Pyrexia, Rash Erythematous, Sepsis
Patient was taking Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, lethargy, nausea (What is nausea?), pyrexia, rash erythematous, sepsis (What is sepsis?) on Feb 06, 2008 from AUSTRALIA Additional patient health information: Female patient , 56 years of age, was diagnosed with non-small cell lung cancer and. Letrozole dosage: 2.5 Mg, Qd. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), RAD001 AND LETROZOLE (10mg, Daily) (View Rad001 And Letrozole Review and Rad001 And Letrozole Label ). Patient was hospitalized.

5624218-5 | Foetal Growth Retardation, Mechanical Ventilation, Premature Baby
Adverse event was reported on Feb 06, 2008 by a Male patient taking Letrozole (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 1.70 lb, Patient had the following side effects: foetal growth retardation, mechanical ventilation, premature baby. During the same period patient was treated with REBIF (Maternal Dose: 44 Mcg, Three Times Weekly) (View Rebif Review and Rebif Label ), GONAL F (View Gonal-f Review and Gonal-f Label ), PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ). Patient was hospitalized.

5616341-6 | Arthritis, Erythema, Pain In Extremity
on Jan 29, 2008 Female patient from GERMANY , 60 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). After Letrozole was administered, patient had the following side effects: arthritis (What is arthritis?), erythema, pain in extremity. Letrozole dosage: 2.5 Mg, Qd. During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ).

5615962-4 | Arthritis, Erythema, Pain In Extremity
on Jan 29, 2008 Female patient from GERMANY , 60 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Letrozole (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), erythema, pain in extremity. Letrozole dosage: 2.5 Mg, Qd. During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ).

5609014-7 | Dehydration
Patient was taking Letrozole (View Usage). Patient had the following side effects: dehydration on Jan 23, 2008 from AUSTRALIA Additional patient health information: Female patient , 56 years of age, was diagnosed with non-small cell lung cancer and. Letrozole dosage: 2.5 Mg, Qd. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), RAD (10mg, Daily) (View Rad Review and Rad Label ). Patient was hospitalized.